ICON announces agreement with Intel allowing Integration of the Intel® Pharma Analytics Platform for Clinical Trials
ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announ...
Continue Reading →
